Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand.
Phyu Sin AyeSandar Tin TinMark James McKeagePrashannata KhwaounjooAlana CavadinoJ Mark ElwoodPublished in: BMC cancer (2020)
Our model may assist clinical decision making for patients in whom tissue-based mutation testing is difficult or as a supplement to mutation testing.